LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 56.24 | 17.25 | 5153 | 4929 | 1.0454 | 1.0109 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 56.24 | 17.25 | 1 | 4929 | 0.0002 | -0.2947 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 56.24 | 17.25 | 6803 | 4929 | 1.3802 | 1.0806 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 58.21 | 17.25 | 248 | 4942 | 0.0502 | 0.3862 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 58.21 | 17.25 | 5433 | 4942 | 1.0993 | 1.0233 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 58.21 | 17.25 | 2 | 4942 | 0.0004 | -0.2320 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 58.21 | 17.25 | 7114 | 4942 | 1.4394 | 1.0913 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 60.18 | 17.25 | 301 | 5031 | 0.0598 | 0.4179 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 60.18 | 17.25 | 5822 | 5031 | 1.1571 | 1.0360 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 60.18 | 17.25 | 2 | 5031 | 0.0004 | -0.2314 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 60.18 | 17.25 | 7483 | 5031 | 1.4872 | 1.0993 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 63.15 | 17.25 | 424 | 5061 | 0.0838 | 0.4779 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 63.15 | 17.25 | 6153 | 5061 | 1.2158 | 1.0482 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 63.15 | 17.25 | 1 | 5061 | 0.0002 | -0.2935 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 63.15 | 17.25 | 7786 | 5061 | 1.5384 | 1.1079 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 65.12 | 17.25 | 401 | 5095 | 0.0787 | 0.4672 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 65.12 | 17.25 | 6532 | 5095 | 1.2820 | 1.0615 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 65.12 | 17.25 | 2 | 5095 | 0.0004 | -0.2309 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 65.12 | 17.25 | 8194 | 5095 | 1.6082 | 1.1192 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 67.09 | 17.25 | 336 | 5221 | 0.0644 | 0.4337 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 67.09 | 17.25 | 6786 | 5221 | 1.2998 | 1.0646 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 67.09 | 17.25 | 2 | 5221 | 0.0004 | -0.2301 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 67.09 | 17.25 | 8469 | 5221 | 1.6221 | 1.1209 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 69.06 | 17.25 | 711 | 5242 | 0.1356 | 0.5697 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 69.06 | 17.25 | 7173 | 5242 | 1.3682 | 1.0775 | MN20160310_N02 | E17 |